Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 1974CancerOpen Access

Combination chemotherapy of advanced lymphocytic lymphoma:Importance of histologic classification in evaluating response

View Full Paper
Ask AI
Bookmark
Share

Authors

ASArthur T. SkarinDana-Farber Cancer InstituteGPGeraldine S. PinkusBrigham and Women's HospitalRMRichard L. MyerowitzUniversity of Pittsburgh

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Skarin et al. (1974) studied this question.

synapsesocial.com/papers/6a1d1dbbba65f5ee325dd30fhttps://doi.org/10.1002/1097-0142(197410)34:4<1023::aid-cncr2820340410>3.0.co;2-7
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Cyclic chemotherapy in lymphoma1971 · 17 citations
  2. 2Combination Chemotherapy in Lymphosarcoma and Reticulum Cell Sarcoma1969 · 114 citations
  3. 3Combination chemotherapy with nitrogen mustard, vincristine, procarbazine, and prednisone in lymphosarcoma and reticulum cell sarcoma1970 · 90 citations
  4. 4Combined cyclophosphamide, vincristine, and prednisone therapy of malignant lymphoma1971 · 196 citations
  5. 5Non-Hodgkin's lymphomas. II. Single agent chemotherapy1972 · 151 citations